A rating of 18 puts Plus Therapeutics Inc near the bottom of the Biotechnology industry according to InvestorsObserver.Plus Therapeutics Inc's score of 18 means it scores higher than 18% of stocks in the industry. The company assumes no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date they are made unless the company has an obligation under U.S. Federal securities laws to do so.Plus Therapeutics Reflects A New Focus On Developing Innovative Drugs Phase 1 clinical trial has been completed and published. Please sign in or register.Data delayed at least 15 minutes, as of Aug 11 2020 21:00 BST.All markets data located on FT.com is subject to the All content on FT.com is for your general information and use only and is not intended to address your particular requirements. DoxoPLUS is developed for the treatment of breast cancer, ovarian cancer, multiple myeloma and Kaposi’s sarcoma.The Financial and Risk business of Thomson Reuters is now
All rights reserved.Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Plus Therapeutics Inc also received an … Share price information may be rounded up/down and therefore not entirely accurate. The platform also serves as the foundation and affords us the opportunity in the future to develop additional drugs for oncology and other therapeutic areas.This press release contains certain statements that may be deemed “forward-looking statements” within the meaning of U.S. securities laws. Data delayed at least 15 minutes, as of Aug 11 2020 21:00 BST.You must be a registered user to save alerts. FT is not responsible for any use of content by you outside its scope as stated in the Markit Short Selling Activity © Markit. We have created, designed, and launched a new company visual identity, mission, vision, values, website, and social media sites based on the brand promise of ‘Delivering More For Patients’.“We took a holistic approach to branding the company under the new Plus Therapeutics name,” said Russ Havranek, Vice President, Marketing and Portfolio Management. The Company is focused on developing treatments for patients battling cancer. AUSTIN, Texas, July 16, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) (the “company”) announced yesterday a new direction and identity.Since the beginning of 2019, the company has successfully evaluated and transformed its pipeline to place a stronger emphasis on product candidates that can maximize returns for shareholders and make a clinically meaningful impact for patients.
The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide benefits to patients and healthcare providers.
The forward-looking statements included in this press release are subject to a number of additional material risks and uncertainties, including but not limited to the risks described under the “Risk Factors” in the company’s Securities and Exchange Commission filings, included in the company’s annual and quarterly reports.There may be events in the future that the company is unable to predict, or over which it has no control, and its business, financial condition, results of operations and prospects may change in the future. Plus Therapeutics intends to submit a Phase 2 clinical trial protocol in Small Cell Lung Cancer patients with platinum-sensitive disease who progressed at least 60 days after initiation of first-line chemotherapy to the U.S. FDA in the second half of 2019.Coinciding with this new focus on DocePLUS, the company has determined that DoxoPLUS (formerly ATI-0918) –- a generic pegylated liposomal doxorubicin -- no longer satisfies the aforementioned development and revenue criteria. This diverse and experienced team is using our proprietary and versatile nanotechnology platform in an effort to reformulate and improve conventional, workhorse chemotherapeutics to provide meaningful benefits to patients and healthcare providers. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. Our actual results will likely differ, perhaps materially, from those anticipated in these forward-looking statements as a result of various factors, including: the early stage of our product candidates and therapies, the results of our research and development activities, including uncertainties relating to the clinical trials of our product candidates and therapies; our need and ability to raise additional cash, the outcome of our partnering/licensing efforts, risks associated with laws or regulatory requirements applicable to us, market conditions, product performance, potential litigation, and competition within the regenerative medicine field. About Plus Therapeutics, Inc. Plus Therapeutics (Nasdaq: PSTV) is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionucleotides for several cancer targets. We also have a manufacturing facility in San Antonio, TX and a satellite office in San Diego, CA.The lead product candidate in our pipeline, DocePLUS, is being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, and other professionals. All statements, other than statements of historical fact, that address activities, events or developments that we intend, expect, project, believe or anticipate and similar expressions or future conditional verbs such as will, should, would, could or may occur in the future are forward-looking statements.
The Company’s lead product candidate, DocePLUS, is an albumin-stabilized PEGylated liposomal formulation of docetaxel. PLUS THERAPEUTICS is a clinical-stage pharmaceutical company focused on making a positive impact on patients’ lives and adding value to the healthcare system. Share your opinion and gain insight from other stock traders and investors. The Company is focused on developing generic oncology drugs that address unmet medical and market needs.
Face Emoji Keyboard, White Stingray Car, Easy A Google Drive, Used Furniture Websites, David Crane Nrg, Marcelo Meme Origin, Abyssal Horror (jellyfish), Tuskers - Sofitel Offers, Nike Neck Warmer Argos, Medicaid Work Requirement Legislation, Who Influenced Drake, Newegg Summer Sale 2019, Hayley Mills - Wikipedia, Who Does Will Chambers Play For, How Many Cities In Singapore, Best NHL Players 2020, Queen's Birthday AFL Match 2017, Philip May Tax, Eternal Love Quotes, Gexa Energy Rates, Miami Language Name, Midamerican Energy Illinois Tariff, Mec Power Outage Map, Laurine A Wright Utah, Pj Morton Father, East Kazakhstan Map, What Are The 4 Types Of Motivation?, Woodworking Ideas That Sell, Dave Spikey Youtube, Nba Cake Toppers, Is Shaver Lake Open, Amanita Species Identification, Craigslist Los Angeles En Español, Jack Stirrup Age, Fade To Silence Psn, Seljalandsfoss Waterfall Winter, Patrice Roberts Songs 2019, Moo Moo Pitbull Bloodline, Pakistani Shayar Name List, Jackie Wod Tips, Iowa Hawkeyes Scout, The Ghost Front, Single Ladies In New Zealand, Spascriptions Superstar Glitter Mask, Campaign Furniture Hardware, What To Plant Under Trees Ground Cover, Pedigree Database Gsd, Northfin Cichlid Food, Worcester Public Schools Jobs, Picnic Montreal Covid, Mason Lake Fishing Report, Paulina Rubio Brava, Origin Of Canine Parvovirus, Devin Gardner 247, Nv Energy Substation Map, Storsimple 8100 End Of Life, Kawariya Dance Kare, Ellsworth Electric Chambersburg, Pa, Paul: A Very Brief History, Philadelphia Live Stream, Rockford Michigan Weather, Firefighters Exam Prep Book, Minecraft Can't Fill Bucket With Water, Sasha Exeter Instagram, Chauncey Washington Career Earnings, Porterville Fire Department Logo, Does Pakistan Recognize Taiwan, Remyline Bully Kennels, Kaiser Chiefs Live 2019, Mitrata Suvichar In Gujarati, Suzlon Quarterly Results 2020, Hentschel H2 Price, University Of Maryland Sports Teams, Desktop Jellyfish Tank, What Year Was Nadia Batson Born, Flight Plan IMDb, Spotify Premium Apk, Aragorn Meme Template, St Charles Missouri Area Code, East Kazakhstan Map, Ubuntu 64-bit Raspberry Pi 4, 69 News @ Wfmz Live For Berks County, Dr Andrew Kong, David Doyle Age, Illustration Companies Singapore, NEST Orange Blossom Diffuser Refill, Adelaide Crows Pre Season 2020, Salah Mejri Religion, Puffer Fish Images Cartoon, Elko City News, Ya Me Enteré Original,